Late-Stage Venture Continues To Dominate Medtech Financing
This article was originally published in Start Up
Executive Summary
Device start-ups raised $1.7 billion in 2013, and approximately 75% of the total was from Series C or later rounds, a sign that investors are still more comfortable making investments in more advanced companies.
You may also be interested in...
Neuromodulation Start-Ups: Abundant Funding, Slow Exits
The field of neuromodulation has produced numerous start-ups and a decent amount of fundraising activity over the past six years, but exits are scarce.
Medtech PIPE Volume, Share Gains Indicate Rebound In Private Investments
A new analysis of medtech PIPE deals in Informa’s Strategic Transactions and PlacementTracker shows a rebound in transaction and dollar volume.
Eight Things That Will Fix Medtech Investing
The last five years have been brutal ones for medical device VCs and entrepreneurs, yet there’s still cause for hope. In a series of interviews, we asked venture capitalists, entrepreneurs, and executives: what gives you hope and what makes you optimistic about the future of medtech?